Premium
Inactivation of MMAC1 in bladder transitional‐cell carcinoma cell lines and specimens
Author(s) -
Liu Juehui,
Babaian David C.,
Liebert Monica,
Steck Peter A.,
Kagan Jacob
Publication year - 2000
Publication title -
molecular carcinogenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.254
H-Index - 97
eISSN - 1098-2744
pISSN - 0899-1987
DOI - 10.1002/1098-2744(200011)29:3<143::aid-mc3>3.0.co;2-a
Subject(s) - biology , transitional cell carcinoma , cancer research , missense mutation , tumor suppressor gene , pten , gene , locus (genetics) , nonsense mutation , microbiology and biotechnology , coding region , mutation , allele , bladder cancer , genetics , carcinogenesis , cancer , apoptosis , pi3k/akt/mtor pathway
We recently limited the location of a candidate tumor suppressor gene in invasive (T3a/b) bladder transitional‐cell carcinoma (TCC) to a 2.5‐cM region at chromosome 10q23.3. This region harbors the MMAC1/PTEN/TEP1 gene (referred to hereafter as MMAC1 ), a dual‐phosphatase tumor‐suppressor gene frequently inactivated in variety of malignant tumors. In the present study, we examined whether MMAC1 is a target for inactivation by mutations and deletions in bladder TCC cell lines and specimens. MMAC1 was inactivated by homozygous deletions and mutations in three (27%) of 11 bladder cancer cell lines. One cell line, UC‐3, had homozygous deletions, and two other cell lines, T‐24 and UC‐9, had missense mutations. T‐24 had also a nonsense mutation. However, none of the 33 bladder TCC specimens examined had a mutation or deletion in the coding region. These results suggest that MMAC1 is not the primary target for inactivation in bladder TCC and that another gene, in close proximity to the MMAC1 locus, within this region of frequent allelic losses, may be the target for inactivation. Mol. Carcinog. 29:143–150, 2000. © 2000 Wiley‐Liss, Inc.